Coherus Biosciences | CHRS - Ebitda





Ebitda 変化する 日付
AbbVie USD 6.91B 3.22B 2026-06
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 120.06M 19.15M 2026-09
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.8B 1.25B 2026-09
Baxter International USD 474M 165M 2026-06
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 9.46B 3.54B 2026-09
Fujifilm JPY 101.61B 48.31B 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Merck USD 1.42B 2.97B 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 156.6M 83M 2026-09
Pfizer USD 6.36B 350M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06
Xencor USD 25.1M 59.73M 2026-09
Zoetis USD 1.07B 21M 2026-09